Furthermore IAPP can interact with and accelerate α‐synuclein aggregation in vitro (although the converse is not true), providing a simple theoretical justification for why T2DM is a risk factor for PD, whereas patients with PD do not have an increased risk of developing T2DM.37 This evidence concerns the gene IAPP and Parkinson disease.